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Plants are man’s first medicines. In ancient times, “medical” care mainly 
involved using plants as medicines. Throughout history, people all over the world 
have used herbs to maintain and improve health into the art of healing. A con-
stant process of searching, testing, and verifying in all cultures across the globe 
resulted in the development of an empirical science. Many plants have an estab-
lished place within scientific medicine and are used for a broad range of health 
conditions. A herb is a plant or its part used for its scent, flavor, or therapeutic 
properties. They are sold as tablets, capsules, powders, teas, extracts, and fresh or 
dried plants.
Herbal medicine as the oldest form of health care is the synthesis of therapeutic 
experiences of generations for over hundreds of years and has gained popularity 
again in today’s medical practice with over 85% of the world’s population using 
phytotherapeutic medicines according to WHO [1].
The increase in the use of herbal products is due to their cultural acceptability, 
availability, affordability, efficacy, and safety claims. Primitive humans distin-
guished useful herbs with beneficial effects from those that were inactive or toxic. 
The basis of modern medicinal drugs such as aspirin, morphine, digitoxin, and 
quinine is through scientific validation of herbal medicine. Review of different 
national pharmacopeia reveals that at least 120 distinct chemical products/moieties 
from herbal sources have been utilized as lifesaving drugs.
In 2010, the inventory of a British-American team of researchers revised 
the previously stated number of plants down from 900,000 plants to between 
300,000 and 400,000 of which only 6% have been screened systematically for 
their biological activity and 15% have been investigated phytochemically and 
just under 10% have had any form of research carried out into the possible use as 
medicines. It is predictable that natural compounds and their derivatives comprise 
nearly 60% of all drugs in clinical use and medicinal plants contribute not less 
than 25% [2].
In medical systems based on herbalism, folklore, or shamanism, written docu-
ments do not exist, and the herbal formulations are often kept secret by the practi-
tioners, making the information more difficult to access [3].
The practices and the philosophy of each herbal medicinal system are influenced 
by their region: Ayurveda, a health care system that has been founded by ancient 
Hindu healers and saints, has been still used in India for over 5000 years. Its mate-
ria medica provides a comprehensive description of over 1500 herbs and 10,000 
formulations. The Indian government has recognized Ayurveda to be a complete 
health care system in comparison with western Medicine and has compiled and pre-
served traditional medicinal knowledge in the public domain with The Traditional 
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Knowledge Digital Library (TKDL). Ayurgenomics aim to provide a base for human 
classification, diagnostics, and customized medicine with Ayurvedic concept of 
Prakriti from pharmacogenomics perspective, and AyuSoft has developed interac-
tive software based on Ayurvedic classics as a decision support system. Herboprint 
uses three-dimensional HPLC to develop tools for activity-based standardization of 
botanicals.
A lot of medicinal plants, traditionally used for thousands of years, are present 
in a group of herbal preparations of the Indian traditional health care system named 
Rasayana proposed for their interesting antioxidant activities.
As metabolic diseases and age-related degenerative disorders are closely associ-
ated with oxidative processes in the body, the use of herbs and spices as a source of 
antioxidants to combat oxidation warrants further attention on validating the anti-
oxidant capacity of herbs and spices after harvest, as well as testing their effects on 
markers of oxidation in parallel with clinical trials aiming to establish antioxidants 
as mediators of disease prevention. From a dietary perspective, the functionality 
of herbs and spices is exposed through consideration of their properties as foods. 
Through evidence-based frameworks for substantiating health claims related to 
foods, recommendations are warranted to support the consumption of foods rich in 
bioactive components, such as herbs and spices in the overall maintenance of health 
and protection from disease. In the book, a chapter is dedicated to the antioxidant 
properties of natural products [4–6].
In China, their own system known as the Traditional Chinese Medicine has been 
used throughout history. The oldest known herbal book in the world “The Devine 
Farmer’s Classic of Herbalism” was compiled in China about 2000 years ago, includ-
ing numerous herbal pharmacopeias and various monographs on specific herbs and 
their composition information.
The first textbook fully devoted to the description of herbal drugs is the Shen-
nung-pen-ts’ao ching (ShenNung’s Classic of Pharmaceutics) was written during 
the later Han period (25–220 AD). The literature of Chinese Materia Medica 
developed by continuous addition of new drugs as well as re-evaluation and addi-
tion of new indications for existing herbs during the centuries has been a valuable 
source for the acquisition of ethnopharmacological data and the development of 
new medicinal plants by studying the ancient textbooks.
The first compound derived from Chinese herbal remedies to enter the western 
market was ephedrine, an amphetamine-like stimulant from ma huang  
(Ephedra sinica).
Kampo medicine, the Japanese herbal medicine dates back over 1500 years with 
approximately 148 formulations [7].
In 1873, the Ebers Papyrus, the most ancient Egyptian medicine treaty—dated 
1600 BC, was found, proving the use of plants for therapeutic purposes.
During the Trojan War (1200 AC), the plant Achillea millefolium was used on 
wounded soldiers in order to stop bleeding and heal wounds [8].
After the fall of the Roman Empire, the tradition of herbal medicine moved to 
the monasteries. The writings of famous healers from earlier times were copied, and 
many monasteries established and maintained herb and medicinal plant gardens, 
which led to the acquisition of new medico-botanical knowledge.
In Germany, herbal medicine is identified as one of the elements of naturopathy, 
and approximately 600–700 plant-derived medicines are accessible and prescribed 
by approximately 70% of German physicians. In 2011, 20% of herbal drugs were 
sold as prescriptions and 80% over the counter in Germany. In the EU, annual 
revenues from herbal medicines surpassed US$ 6 billion in 2003.
The National Canadian Institutes disbursed approximately 89 million dollars for 
research in traditional therapies in 2004.
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In 2005, the National Centre for Complementary and Alternative Medicine at 
the National Institutes of Health in the USA spent about 33 million US dollars on 
herbal medicine.
In recent decades, the pharmacological properties of numerous medicinal plants 
and opportunities in phytotherapy have been explored through research projects, 
reviews, and monographs. These studies confirm that medicinal plants offer new 
approaches to tackling diseases. Herbal medicine has become a popular form of 
health care; even though several differences exist between herbal and conventional 
pharmacological treatments, herbal medicine needs to be tested for efficacy using 
conventional trial methodology. The public is often misled to believe that all natural 
treatments are inherently safe, but herbal medicines do carry risks. The triad 
absorption/metabolism/efficacy of herbs and their extracts is still an unsolved 
problem in judging their health effects. Some side effects such as allergic reactions, 
mutations, intoxication, teratogenesis, carcinogenesis, and medication interactions 
may occur if the use of the phytotherapeutic or medicinal plant is unrestricted. The 
lack of a stricter control of these medicines enables contamination by heavy metals, 
conventional drugs, herbicides or pesticides [9].
Based on World Health Organization reports, resistance of bacteria to antibiot-
ics is a major global health challenge now and in the future. Different strategies 
such as inhibition of multidrug resistance pumps and biofilm formation in bacteria 
and development of new antibiotics with novel mechanism of action have been 
proposed to tackle this problem. Flavonoids, a large class of natural compounds, 
have been extensively studied for their antibacterial activity, in more than 150 
articles published since 2005 and especially chalcones showed up to sixfold stronger 
antibacterial activities than standard drugs in the market. Some synthetic deriva-
tives of flavonoids also exhibited remarkable antibacterial activities with 20- to 
80-fold more potent activity than the standard drug against multidrug-resistant 
Gram-negative and Gram-positive bacteria (including Escherichia coli, Pseudomonas 
aeruginosa, and Staphylococcus aureus). Some of the flavonoids (i.e., quercetin) with 
a strong background of use in clinical trials are good candidates for further clinical 
studies as antibiotics alone or in combination with conventional antibiotics [10].
In the concept of the “doctrine of signatures,” the healing effect of plants was 
deduced from their taste, shape, color, and other characteristics, for example, 
celandine (Chelidonium majus L.) being used as a remedy for the gallbladder and 
liver because of its yellow sap, orchids being used as an aphrodisiac because of 
their tubers resembling male testicles, and walnuts being used for mental illnesses 
because of their appearance resembling the surface of the brain.
The Nobel Prize in Physiology and Medicine 2015 was awarded for the discovery 
of two main natural products: (1) avermectin, a macrocyclic lactone isolated from 
the soil microorganism Streptomyces avermitilis (and its derivative ivermectin) and 
(2) artemisinin, a sesquiterpene lactone containing a peroxide bridge, isolated from 
the plant Artemisia annua L. (Asteraceae) [11].
The World Health Organization (WHO) defines herbal medicine as a practice, 
which includes herbs, herbal materials, herbal preparations, and finished herbal 
products, which contain as active ingredients parts of plants or other plant materials 
or combinations. These herbs are derived from plant parts such as leaves, stems, 
flowers, roots, and seeds.
Modern or scientific herbal medicine is also called phytomedicine or phyto-
therapy. Phytotherapy is a science-based medical practice with more traditional 
approaches, such as medical herbalism, which relies on an empirical appreciation of 
medicinal herbs linked to traditional knowledge.
Phytotherapy is defined as the study of the use of extracts of natural origin as 
medicines or health-promoting agents in an allopathic discipline, because they are 
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directed against the causes and the symptoms of a disease. In Germany, phyto-
therapy is classified as a discipline of natural orthodox science-oriented medicine, 
with scientific requirements of the chemically defined substances in terms of 
quality, safety, and efficacy. Modern mass production of natural products as food 
supplements or herbal medicines may result in remedies that can differ greatly 
(dosage form, mode of administration, herbal medicinal ingredients, methods 
of preparation, and medical indications) from the traditions that form the basis 
for their safety and effectiveness, and an acceptable quality standard. The WHO 
has published monographs on the quality control, safety, and efficacy of selected 
medicinal plants and recommendations on their cultivation.
According to the World Health Organization, phytomedicine is defined as herbal 
preparations produced by subjecting plant materials to extraction, fractionation, 
purification, concentration, or other physical or biological processes. These prepa-
rations may be produced for immediate consumption or the basis for other herbal 
products. Such plant products may contain recipient or inert ingredients, in addi-
tion to the active ingredients.
Paraherbalism describes alternative and pseudoscientific practices of using 
unrefined plant or animal extracts as unproven medicines or health-promoting 
agents [12].
An herb may be any part of a plant including its leaves, stem, flowers, roots, and 
seeds. Herbal products may be raw or commercial preparations used to treat ill-
nesses. Raw herbal products (leaves, seeds, or teas) are more used in less developed 
countries and commercial herbal preparations (tablets or pills) are more used in 
developed countries.
WHO published the requirements for clinical trials of herbal products, which 
contain the following definitions:
1. Herbal substance—material derived from the plant(s) by extraction, mechani-
cal manipulation, or some other processes
2. Herbal product—the herbal material administered to clinical subjects
3. Herbal product synonyms—herbal remedy, herbal medicine, herbal drug, and 
botanical drug [13]
Herbal drugs, called phytochemicals, are the secondary metabolites of plants. 
Some are toxins, used to deter predation; some are pheromones, used to attract 
insects for pollination; others are phytoalexins, which protect against microbial 
infections; and yet others are allelochemicals, which inhibit rival plants competing 
for soil and light.
The first generations of plant medicine were simple botanical materials 
employed in more or less crude form. These medicines such as Cinchona, Opium, 
Belladonna, and Aloe were selected based on empirical evidence as gathered by 
traditional practitioners.
The second-generation phytopharmaceutical agents were pure molecules 
whose compounds differ from the synthetic therapeutic agent only in their origin, 
for example taxol from Taxus spp., quinine from Cinchona and reserpine from 
Rauvolfia spp.
In the development of third generation of plant medicine, the formulation 
is based on well-controlled double-blind clinical and toxicological studies with 
phytomedicine to improve the quality, efficacy, stability, and the safety of the 
preparations.
The following are characteristics of the phytomedicine:
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• The active principle is frequently unknown.
• Standardization, stability, availability, and quality control are not easy.
• Well-controlled double-blind clinical and toxicological studies to prove their 
efficacy and safety are rare.
• They are cheaper than synthetic drugs.
• The belief that phytomedicine is devoid of side effect since millions of people 
all over the world have been using phytomedicine for thousands of years.
• The belief that phytomedicine is used for a wide range of treatment, especially 
of certain diseases where conventional medicine fails.
They are gentle, effective, and often specific in function to organs or systems of 
the body [14].
Although synthetic or chemical drugs can have greater or quicker effects than do 
equivalent phytomedicines, they present a higher degree of side effects and risks. 
For instance, psychopharmacological products with sedative and anxiolytic action 
are accompanied by undesirable side effects like uncoordinated motor skills and 
drowsiness, but phytomedicine acts on the body by regulating and balancing its 
vital processes rather than stopping or combatting certain symptoms. Its balancing 
effect prevents mental disorders and unbalanced mental condition.
The action of phytomedicines for the respiratory system is not limited to neutraliz-
ing the symptoms of any disease, but they also exert a true cleansing action for exces-
sive mucus in the interior of the airway. They contain certain antibiotic substances 
that prevent bacteria growth in the mucus, for example Thymus vulgaris (thyme) and 
Allium sativum (garlic). Naringenin chalcone as the effective constituent of tomato 
extracts has been shown to inhibit the release of histamine from mast cells in the 
initial phase of inflammation and decrease the eosinophils and eosinophil cationic 
proteins by significantly improving nasal obstruction, rhinorrhea, and sneezing [15].
Phytomedicines are good dietary supplements, which are nutritive and replenish 
the body. For example, sunflower seed (Helianthus annuus) provides vitamin B6 
(Pyridoxine).
Phytomedicines are effective in curing human pathogens like E. coli and Candida 
albicans, beyond symptomatic treatment of diseases and limit side effects associ-
ated with synthetic antimicrobial drugs. For example, Hydrastis canadensis not only 
has antimicrobial properties but also promotes optimal activity of the spleen in 
releasing compounds by increasing the blood flow in the spleen.
Recognition and application of phytomedicine depend on evidence-based clini-
cal data. Phytomedicine can only enter in professional clinical application if safety, 
efficacy, and quality are proven in a comparable manner to conventional drugs. For 
this purpose, it is mandatory to conduct well-designed clinical trials. Awareness of 
Good Clinical Trial Practice and provision of knowledge worldwide is the existen-
tial foundation for proper scientific development [16].
“Medicinal plants” are neither phytomedicines nor phytotherapeutics. Once 
classified as a medicine, it is subject to the ethical standards defined by World Health 
Organization (WHO), and has to go through careful production processes from the 
time of collection and formulation until the time of packaging and distribution.
A plant may contain even thousands of chemical compounds acting in a syn-
ergistic way. Many conventional test methods are not always able to cope with the 
complexity of plant extracts to confirm the empirical and traditional use of a herb.
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Many big pharmaceutical companies and scientists are returning to nature’s 
apothecary in the search of new medicines [17].
Rational drug discovery from plants started when the German apothecary assis-
tant Friedrich Sertürner isolated the analgesic and sleep-inducing agent from opium, 
which he named morphium (morphine) after the god of dreams, Morpheus, in 
1805. This was followed in succession by many other herbal remedies or phytophar-
maceutical substances (referred to in international terminology as HMPs or Herbal 
Medicinal Products). Strychnine from the poison nut tree (Strychnos nux vomica) 
in 1819, caffeine from the coffee bean (Coffea) in 1819, quinine from red cinchona 
(Cinchona pubescens) in 1820, codeine from opium in 1832, digitoxin from the purple 
foxglove (Digitalis purpurea), strophanthin from the seeds of the African climber 
(Strophanthus gratus), and atropine from deadly nightshade (Belladonna atropa) were 
important milestones in the discovery and isolation of plant-based constituents.
H.E. Merck in Darmstadt (Germany), the first apothecary extracting morphine 
and other alkaloids, was the first progenitor of pharmaceutical companies, which 
subsequently have produced natural products by chemical synthesis in order to 
facilitate production at higher quality and lower costs. Salicylic acid was the first 
natural compound produced by chemical synthesis in 1853.
The modern pharmaceutical industry laid its scientific and financial foundation 
after the discovery of penicillin (1928) from microbial sources. The therapeutic use of 
extracts and partly purified natural products has then been replaced by the use of pure 
compounds. For example, in the area of cancer, over the time frame from 1940s to the 
end of 2014, of the 175 small molecules approved 131, or 75%, are other than “S” (syn-
thetic), with 85, or 49%, the actually being either natural or directly derived products.
Many big and medium-sized pharmaceutical companies have leaved their natu-
ral product research programs to academic universities and start-up companies [18].
Ethnobotany, as a research field of science, has been used for the documentation 
of indigenous knowledge on the use of plants for providing an inventory of useful 
plants from local floras. Plants that are used for traditional herbal medicine in differ-
ent countries are an important part of the ethnobotanical studies, for the discovery 
of new drugs and new drug development. Over-harvesting, degradation of medical 
plants, and loss of traditional medical knowledge in local communities are common 
problems in the resource areas as well as issues of indigenous knowledge, intellectual 
property rights, and uncontrolled transboundary trade in medicinal plants [19].
Phytomedicine has become an important alternative treatment option for 
patients, as they seek to be treated in a holistic and natural way after an unsatisfac-
tory response to conventional drugs.
Medical treatments cover the application of different components of plants (blos-
som, leaf, stem, and radix), aromatic essential oils, and herbal extracts as herbal teas, 
via massage as packs or wraps or in therapies using water, steam, or inhalation.
Although these subjects lost their importance in twentieth century because of 
the modern synthetic treatments, there is a renewed interest today in medicinal 
plants usage as natural products for the generation of semi-synthetic derivatives.
Currently, the paradigm of medicine has shifted from not only curing clinical 
diseases but also maintaining good health and enhancing quality of life with the 
integration of traditional medicine into the modern health care system [20].
2. Homeopathy
In conventional medicine, drugs are generally used to combat the symptoms of 
an illness. This principle is called allopathy (directed against an ailment) as well as 
for phytotherapy.
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In homeopathy (similar to the ailment), a substance in diluted (potentized) 
form, which produces certain phenomena in healthy people, has a healing effect for 
a patient suffering from the same phenomena.
Common features of homeopathy and phytotherapy are that they emphasize a 
holistic approach and the regulation of self-healing powers and they are based on 
empirical values.
In determining the outcome of any traditional treatment, both in experimental 
and clinical settings including forma mentis, beliefs, knowledge, and practical abili-
ties of the provider, as well as the positive or negative prejudices of the patient with 
respect to the provider of the therapy, cultural differences in the acceptability of 
the treatment and adherence to it, the patient-doctor encounter and differences in 
access to other treatments should be taken into consideration.
3.  Traditional medicine and complementary and alternative  
medicine (TM/CAM)
The World Health Organization (WHO) distinguishes terminologically between 
traditional medicine and complementary and alternative medicine (TM/CAM). 
The WHO refers the term traditional medicine to developing countries (in Africa, 
Latin America, Southeast Asia, and/or the Western Pacific), as indigenous medicine 
(Traditional Chinese Medicine, Hindu Ayurveda, Arab Unani, and various forms of 
indigenous medicine) deeply rooted in history. The WHO uses the term CAM when 
referring to developed countries.
According to the World Health Organization (WHO), TM is “the sum total of 
the knowledge, skills and practices based on the theories, beliefs and experiences 
indigenous to different cultures, whether explicable or not, used in the maintenance 
of health, as well as in the prevention, diagnosis, improvement, or treatment of 
physical and mental illnesses, which may rely exclusively on past experience or 
observation handed down from generation to generation, verbally or in writing.” 
It comprises therapeutic practices in existence for hundreds of years before the 
development of modern scientific medicine and is still in use today without much 
documented evidence of adverse effects [21].
TM therapies include medication therapies—use of herbal medicines, animal 
parts, and/or minerals—and nonmedication procedure-based therapies—without 
the use of medication, as in the case of acupuncture and related techniques, manual 
therapies, chiropractic, osteopathy, qigong, tai ji, yoga, naturopathy, thermal 
medicine, and other physical, mental, spiritual and mind-body therapies.
In countries where the dominant health care system is based on allopathic 
medicine, or where TM has not been incorporated into the national health care 
system, TM is termed as “complementary,” “alternative,” or “nonconventional” 
medicine.” The term “traditional medicine” denotes the indigenous health tradi-
tions of the world; “complementary and alternative medicines” refer to methods 
outside the biomedical mainstream, as a set of health care practices that are not 
part of a country’s own tradition and are not integrated into the dominant health 
care system, particularly in industrialized countries; and “conventional medicine” 
refers to “biomedicine” or modern medicine. Other terms that describe these health 
care practices, include “natural medicine,” “nonconventional medicine,” or “holistic 
medicine.” The terms complementary/alternative/nonconventional medicine are 
used interchangeably with traditional medicine in some countries [22].
WHO’s quality-of-life assessment of many traditional and complementary 
health systems includes spiritual dimensions of life and well-being, which is related 
to the sense of the meaning of the self or extending beyond the self. Expectancy 
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based on belief and attitude causes a placebo, or “meaning response” effect on 
treatment outcomes in all therapeutic settings.
The traditional and complementary and alternative medicine (T/CAM) have 
claimed an increasing share of the public’s awareness and the agenda of medical 
researchers. About half the population of many industrialized countries use T/
CAM, (United States, 42%; Australia, 48%, France, 49%; Canada, 70%) and the 
proportion is as high as 80% in many developing countries (China, 40%; Chile, 
71%; Colombia, 40%; up to 80% in African countries). Accompanied by a growth in 
research and associated literature, with an increase in an evidence-based approach, 
T/CAM has long been practiced both within and outside the dominant health care 
system. Most research has focused on clinical and experimental medicine (safety, 
efficacy, and mechanism of action) and regulatory issues, to the general neglect 
of public health dimensions. Public health research must consider social, cultural, 
political, and economic contexts to maximize the contribution of T/CAM to health 
care systems globally. A public health agenda is needed in addition to the focus on 
experimental research. Public health professionals need to define the public health 
dimensions of traditional and complementary medicines.
Practices of traditional medicine vary greatly from country to country, and from 
region to region, as they are influenced by factors such as culture, history, personal 
attitudes, and philosophy. In many cases, their theory and application are quite 
different from those of conventional medicine. The theories and concepts of pre-
vention, diagnosis, improvement, and treatment of illness in traditional medicine 
(both herbal medicines and traditional procedure-based therapies) historically rely 
on a holistic approach toward the sick individual, and disturbances are treated on 
the physical, emotional, mental, spiritual, and environmental levels simultaneously 
taken into account the cultural background. As a result, most systems of traditional 
medicine may use herbal medicines or traditional procedure-based therapies along 
with certain behavioral rules promoting healthy diets and habits. Holism is a key 
element of all systems of traditional medicine.
Traditional medicine has not only continued to be used for primary health care 
of the poor in developing countries, but has also been used in countries where con-
ventional medicine is predominant in the national health care system. Despite its 
existence and continued use over many centuries, and its popularity and extensive 
use during the last decade, traditional medicine has not been officially recognized 
in most countries. Long historical use of many practices of traditional medicine, 
including experience passed on from generation to generation, has demonstrated 
the safety and efficacy of traditional medicine. However, scientific research and 
evaluation of the traditional medicine are needed to provide additional evidence of 
its safety and efficacy, considering knowledge and experience obtained through the 
long history of established practices.
With the tremendous expansion in the use of traditional medicine worldwide, 
safety and efficacy as well as quality control of herbal medicines and traditional 
procedure-based therapies have become important concerns for both health 
authorities and the public. Various practices of traditional medicine have been 
developed in different cultures in different regions without a parallel development 
of international standards and appropriate methods for evaluating traditional 
medicine. Governments and researchers, among others, are increasingly requesting 
WHO to provide standards, technical guidance, and information to ensure that 
traditional medicine is used properly and to determine how research and evaluation 
of traditional medicine should be carried out.
Consequently, education, training, and research in this area have not been 
accorded due to attention and support. The quantity and quality of the safety and 
efficacy data on traditional medicine are far from sufficient to meet the criteria 
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needed to support its use worldwide. The reasons for the lack of research data 
are due not only to health care policies but also to a lack of adequate or accepted 
research methodology for evaluating traditional medicine. It should also be noted 
that there are published and unpublished data on research in traditional medicine in 
various countries, but further research in safety and efficacy should be promoted, 
and the quality of the research should be improved.
Since 1991, WHO has developed and issued a series of technical guidelines such as 
guidelines for the assessment of herbal medicines, research guidelines for evaluating 
the safety and efficacy of herbal medicines, and guidelines for clinical research on 
acupuncture. However, these guidelines are still not sufficient to cover the many chal-
lenging issues in the research and evaluation of traditional medicine. In 1997, with the 
support of the National Center of Complementary and Alternative Medicine, National 
Institutes of Health, Bethesda, MD, USA, a WHO informal discussion developed draft 
guidelines for methodology on research and evaluation of traditional medicine.
Traditional medicine (TM), variously known also as ethno-medicine, folk 
medicine, native healing, or complementary and alternative medicine (CAM), is 
the oldest form of health care system as an ancient and culture-bound method of 
healing that humans have used to cope and deal with various diseases that have 
threatened their existence and survival. Different societies have evolved different 
forms of indigenous healing methods e.g., Chinese, Indian, and African traditional 
medicines. Traditional healer, on the other hand, is “a person who is recognized by 
the community where he or she lives as someone competent to provide health care 
by using plant, animal, and mineral substances and other methods based on social, 
cultural, and religious practices” [23].
4. Traditional medicine in Africa
Prior to the introduction of the cosmopolitan medicine, traditional medicine 
(TM) used to be the dominant medical system available to millions of people in 
Africa in both rural and urban communities as the only source of medical care for a 
greater proportion of the population.
The traditional health care systems are still in use by the majority of the people 
not only in Africa but across the world. In indigenous African communities, the tra-
ditional healers treat patients holistically by reconnecting their social and emotional 
equilibrium based on community rules and relationships unlike medical doctors 
who only treat diseases in patients. The arrival of the Europeans marked a signifi-
cant turning point in the history of this age-long tradition and culture. During 
several centuries of conquest and invasion, European systems of medicine were 
introduced by colonizers and preexisting African systems were stigmatized and 
marginalized. Indigenous knowledge systems denied the chance to systematize and 
develop and even banned in some extreme cases. They were believed to be primitive 
and wrongly challenged by foreign religions dating back during the colonial rule in 
Africa and subsequently by the conventional or orthodox medical practitioners. In 
postindependence period, after a century of colonialism and cultural imperialism, 
TM has been recognized and held back the development of African traditional 
health care as an important aspect of health care delivery system in Africa. Despite 
the “passionate ambivalence,” TM is still in use in modern day Africa after hundreds 
of years of its existence as a major African socio-cultural heritage without much 
reported cases of adverse effects.
The new health agenda in Africa focuses on the institutionalization of tradi-
tional medicine in parallel with orthodox medicine into the national health care 
scheme in order to move the health agenda forward since effective health cannot 
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be achieved in Africa by orthodox medicine alone unless it has been complemented 
with traditional medicine.
As a whole, the annual market value of phytomedicine is close to $43 billion in 
all the world (more than some African annual budgets). Many African phytomedi-
cines are well known in the international markets and Africa is one of the main 
world producers of the medicinal plants. For example, Cinchona yields quinine, an 
antiplasmodial drug for the treatment of malaria.
The WHO has helped most developing countries of the world by utilizing 
expert committees’ policy decisions, and resolutions in providing guidelines that 
will aid the countries to develop and utilize their indigenous medicines for their 
national health agenda. In Africa, the health agenda is targeted at the recognition 
and development of phytomedicines by indigenous medical and pharmaceutical 
research scientists. This has lead the African Heads of States to declare the first 10 
years of the millennium (2001–2010) as the “Decade of Traditional Medicine in 
Africa” and to celebrate on 31st August every year to make sure that phytomedicine 
is recognized and appreciated in the health sector.
WHO has offered a memorandum to help African member states in institu-
tionalizing African traditional medicine in their health system and challenging 
different African Research centers on traditional medicine to cure priority 
diseases in Africa, such as malaria, HIV/AIDS, sickle-cell anemia, diabetes, and 
hypertension.
WHO has provided guidelines for institutionalization of traditional medicine 
into the health scheme including the below steps:
1. Political recognition: the government and heads of states should develop 
research on traditional medicine for the treatment of priority diseases as they 
declared 2001–2010 as “Decade of African Traditional Medicine” at the African 
Summit of Heads of States.
2. Development of policy, legal and regulatory framework: governments should 
formulate national policies, legal frameworks, and registration according to 
the guidelines that WHO has provided for the assessment of herbal medi-
cine to establish regional regulatory mechanisms regulating herbal medicine 
through national expert committees.
3. Promoting scientific research on traditional medicine and collaboration 
work: scientific research should be conducted on safety, efficacy, and qual-
ity of traditional medicine primarily used for the management of priority 
disease like malaria, HIV/AIDS, sickle-cell anemia, diabetes, and hyperten-
sion as proposed by WHO. Collaboration of traditional medicine practitio-
ners with the scientific community can be achieved through staff exchange 
and training, sharing expensive equipment and joint publications by making 
partnership arrangements also with the private sector for the integration of 
traditional medicine.
4. Ensuring that intellectual property rights are protected: intellectual property 
rights of the indigenous knowledge about traditional medicine should be pro-
tected by particular legislation.
5. Disseminating appropriate information to the general public on the use of 
traditional medicine: appropriate information should be given to the general 
public to empower them with knowledge and skills for the proper use of tradi-
tional medicine through organization of seminars to raise awareness.
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6. Providing a good economic environment: the government should ensure a 
good economic, political, and regulatory environment for local production by 
traditional herbal practitioners as well as develop industries that can produce 
standardized remedies to increase access and provide funding for their smooth 
operations.
There are many factors hindering the development of phytomedicine in Africa:
• Development of drug from its natural source is more difficult than synthetic 
drug development; formulation of phytomedicine particularly in crude-drug 
form requires a specialized expert area of training and experience.
• Lack of standardization and quality control of the herbal drugs used in clinical 
trials.
• The risk of side effects due to:
 ○ toxicity,
 ○ over-dosage,
 ○ interaction with conventional drugs,
 ○ manufacturing problems such as misidentification of plants,
 ○ lack of standardization,
 ○ failure of good manufacturing practice,
 ○ contamination as a result of field microbial contamination,
 ○ poor packaging,
 ○ the bad environmental condition (temperature, light exposure),
 ○ substitution and adulteration of plants, and
 ○ incorrect preparation and dosage.
• Imprecise diagnosis and dosage for phytomedicine.
• The lack of communication and collaborative research among orthodox medi-
cal practitioners and scientists threaten to lose the ethnomedical knowledge 
concerning the plant and other aspects of the medicinal system.
• Inadequate randomizations in most studies. Patients are not properly selected 
and the numbers of patients used in most trials are insufficient for the attach-
ment of statistical significance.
• Problem of serious attention, resource mobilization, commitment, and the 
required political will.
• There is a wide variation in the duration of treatment using herbal medicine.
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• Domestication: it is difficult to convince members of the community to trust 
phytomedicine after a long use of orthodox medicine.
• There is absence or inadequate record of what is available and many species are 
becoming extinct because they are not cultivated and protected from indiscrim-
inate harvesting. Also, the traditional healers are of advancing age and dying.
• Unfavorable legislation such as Witchcraft Act.
The quality and stability of phytomedicine is achieved by the use of fresh plants, 
regulated physical factors like temperature, light, water availability, and cultivation 
of plants in place of wild-harvested plants, because they show smaller variation in 
their constituents. The standardization of phytomedicine can also be achieved by 
the use of chromatography, infrared, and ultraviolet (UV) spectrometry.
The African pharmacognosists, pharmacologists, pharmacists, and physicians 
have to learn, acquire, document, and use traditional medicine to help curtail the 
extinction of plants and human resources. Collaborative work can be achieved 
through staff exchange and training and funding for capital building:
the government should help in funding researches on phytomedicine;
the private sector as well as nongovernmental agencies should help finance 
researches;
organization of seminars to raise awareness to the general public on the benefits 
of medicinal plants and remove the perception that scientists are out to harness 
their knowledge for money making;
abandoning outdated legislation (such as witchcraft Act); and
passing new legislation to protect indigenous traditional knowledge to integrate 
into the health scheme.
As medicinal plants are going global with increasing demand in the phytothera-
peutic market, the following factors must be emphasized in Africa for the develop-
ment of phytomedicine:
• Emphasis on well-controlled and randomized clinical trials to prove the safety 
and efficacy of herbal medicine. With the growth of the botanical market, the 
quality, efficacy, and safety of phytomedicine used in clinical trials have to 
be improved to produce standardized drugs and to develop novel therapeutic 
methods with researches on traditional medicines.
• An improvement in the processes of regulation and global harmonization of 
phytomedicine. The integration of African traditional medicine into the health 
system should bring harmony between traditional and modern systems of 
health care with minimum threat to each other.
• Greater emphasis should be placed on collaboration work in order to bring tra-
ditional healers closer to scientists by engaging and training them in laboratory 
work, as well as get information on traditional prescriptions for specific diseases.
• Emphasis has to be placed on domestication, production, biotechnological 
studies, and genetic improvement of medicinal plants. The domestication 
of plants will reduce the effects associated with wild-harvested plants, avoid 
misidentification and field contamination.
Increase the quality of raw materials and yield through genetic breeding and 
selection.
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Production of phytomedicine with resistance to microorganism-induced diseases.
• Detailed legislation on the ownership of intellectual property right has to be made.
Research has shown that a number of traditional medicines are effective thera-
peutic regimens in the management of a wide spectrum of diseases especially those 
which may not be effectively managed using Western medicines. Furthermore, 
inadequate accessibility to modern medicines and drugs to treat and manage dis-
eases in middle- and low-income countries, especially in Africa, may have contrib-
uted to the widespread use of TM especially in poor households.
Besides accessibility to traditional healers, TM provides an avenue through which 
cultural heritages are preserved and respected. Indeed, TM practice is in line with 
the socio-cultural and environmental conditions of the people who use it in Africa.
Traditional medicine is becoming increasingly popular across the world. 
However, its growth potential has been understudied and poorly appreciated due to 
existing global political economy of health and any surrounding informal processes.
In developed countries, on the other hand, factors responsible for the wide-
spread use of TM are beyond accessibility, affordability, and cultural compatibility. 
According to the World Health Organization anxiety about the adverse effects 
of chemical drugs, improved access to health information, changing values, and 
reduced tolerance of paternalism are some of the factors responsible for the grow-
ing demand for CAM in developed countries.
Traditional medicine in Africa is contrasted with biomedicine. Most traditional 
medical theories have a social and religious character and emphasize prevention 
and holistic features. Traditional medical practices are usually characterized by 
the healer’s personal involvement, by secrecy and a reward system. Biomedical 
theory and practice show an almost opposite picture: asocial and irreligious with 
professional detachment. Local communities do not expect that basic health care 
will improve when traditional healers become integrated into the service. They ask 
instead for improvement of basic health care itself: more services with better access, 
more dedication and respect from doctors and nurses, and more medicines and 
personnel. Fieldwork needs to be done at the community level to arrive at a better 
understanding and assessment of the community’s opinion concerning a possible 
role of traditional medicine in basic health care.
WHO has been working with African nations to integrate scientific and medical 
models of health to enhance the potentials of traditional medicine in the control of 
endemic diseases.
Intelligent application of traditional therapies have made useful contributions 
to alleviate sickness and suffering in Africa. Efforts should be made to protect 
plants from going extinct. The people and Orthodox practitioners need to be given 
appropriate information on phytomedicine. The integration or harmonization 
of phytomedicine should be developed in such a way to work hand-in-hand with 
orthodox medicine with minimum threat to each other [24–26].
In the book one, chapter is dedicated to the traditional medicine in Africa.
5. Biofield therapies
Biofield, a term coined during the US National Institutes of Health Conference 
in 1992, is defined as “a massless interacting field of energy and information that 
surrounds and permeates living systems.”
Biofield therapies are noninvasive therapies in which the practitioner manipu-
lates individuals’ energy field in order to stimulate his/her healing responses.
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The National Institutes of Health Center for Complementary and Alternative 
Medicine (NCCAM) has classified energy medicine therapies into two basic catego-
ries: bioelectromagnetic-based and biofield therapies. Bioelectromagnetic-based 
therapies involve the use or manipulation of electromagnetic fields (EMFs).
Biofield modalities, which sense and modulate surrounding “subtle energy 
fields” and interpenetrate the human body, have existed for thousands of years in 
a wide range of cultures. The vital energy concepts, which include the Indian term 
prana, the Chinese term ch’i, and the Japanese term qi, refer to subtle or nonphysical 
energies. Similar concepts in the West are reflected in the concepts of Holy spirit, or 
spirit, and can be dated back to the writings in the Old Testament.
A common thread is the development of specific techniques that use subtle 
energy to stimulate one’s own internal (intrapersonal) healing process, by 
movement-oriented practices such as yoga, tai-chi, or internal qigong, as part of the 
experience of meditation or prayer.
External (interpersonal) practices specifically use subtle energies for the process 
of healing another person, including local or proximal practices such as external 
Qigong, pranic healing, where a healer transmits or guides energy to a recipient 
who is physically present as well as distance practices where a healer sends energy 
to a recipient in a different physical location, such as intercessory prayer or distance 
healing.
A major distinction in biofield therapies involves whether the practitioner 
engages the patient’s biofield with (hands-on) or without physical contact (hands-
off). Some modalities such as Reiki and Brennan healing contain techniques that 
are both hands-on and hands-off (but in close proximity), others such as Johrei 
and external qigong are practiced with hands at a slightly further distance from the 
body.
Biofield therapies are inexpensive compared with the costs of other types of 
therapy and effective to relieve daily life stress of patients by reduction in tension, 
anxiety, and pain with minimum side effects.
Biofield activities stimulate specific brain areas allowing for differentiation of 
certain moods. Humans distinguish between pleasant or unpleasant stimuli, based 
upon biofield information transmitted to the autonomic nervous system, immune 
system, and the endocrine system, so biofield therapy exert an influence through-
out the entire human body.
The majority of practices intended to affect the body’s energy flow do not 
involve devices. Energy Medicine Practices that benefit energy flow and overall 
energy in the body include certain forms of exercise, mechanical manipulation, 
pressure, light, sound, scent, touch, position, the use of electrical current or mag-
netic pulses, or movement to stimulate the body’s own energy systems. Exercises 
of the energy medicine require a trained and authorized instructor to teach the 
technique (Pilates, Tai Chi) and rely either on manipulation (Alexander Technique, 
Cranial-sacral), on movement (Feldenkrais, FlexAware), on positions (yoga) or 
on scents (aroma therapy). Some practices that focus on particular areas of the 
body require touching (massage, reflexology, Reiki) and some others do not require 
touching (medical Qigong).
Although science has provided considerable information about how the body 
works, it cannot explain yet what differentiates living and nonliving matter and 
why the placebo effect is stronger than most drugs and the roles of attitude and 
intention, as well as the mechanisms by which they work, which may or may not be 
related to the placebo effect [27].
Biofield physiology is proposed as a descriptor for the electromagnetic, biopho-
tonic, and other types of spatially distributed fields that living systems generate and 
respond as integral aspects of the self-regulation and organization of cell, tissue, 
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and whole organism. Individual molecules can act as transmitting and receiving 
antennae in the mediation of efficient intermolecular communication via single 
photons.
As a means of information transfer, biophotons have the advantages of 
extremely high speed and the ability to penetrate through cell membranes that pres-
ent barriers to the diffusion of molecular signals.
Electrical and magnetic fields, as well as biophotons in the full range from 
ultraviolet to infrared, are detected during normal physiological activity including 
the resonance signaling, and the modulation of cell function by specific electromag-
netic frequencies.
Biologically generated biofields are a spatially distributed set of forces and 
physical properties that have the capacity to encode information and exert instruc-
tive influences on cells and tissues capable of perceiving and being modified by 
them [28].
Electric fields generated by the intracellular network of microtubules, centro-
somes, and chromosomes play fundamental roles in regulating the dynamics of 
mitosis, meiosis, and a variety of other cellular activities [29].
Electric charge in motion, whether along a wire or a nerve axon, produces a 
magnetic field in the surrounding space, a type of biofield. Magnetic fields emanat-
ing from the body, although extremely weak relative to the geomagnetic field of 
the earth, are readily detected by superconducting quantum interference device 
(SQUID)–based magnetometers [30].
The strongest rhythmic electrical and magnetic fields in the body are produced 
by synchronous activity of arrays of the heart muscle cells and can be detected, as 
electrocardiogram (ECG) or magnetocardiogram (MCG). The heart’s magnetic 
field also carries information that can also be detected by other persons or animals 
and can be recorded up to several feet from the body surface.
An example of the informational potential (bioeffectiveness) of the heart 
biofields is cardiac-induced entrainment, or frequency locking, detected when the 
R-waves of one subject’s ECG become precisely synchronized with the onset of EEG 
alpha waves of another subject at a distance of up to 5 feet.
Heart fields may also encode psychoemotional information, as indicated by the 
75% accuracy rate in detecting discrete emotional states from patterns of heart rate 
variability.
The electrical and magnetic fields generated by the composite activity of 
thousands of brain cells are detected as an electroencephalogram (EEG) or mag-
netoencephalogram (MEG). At a functional level, the electromagnetic activity of 
neural assemblies modulates neuron synchronization and circadian rhythmicity 
and the computational and cognitive processes of the brain. More specifically, weak 
sinusoidal electric fields enhance and entrain physiological neocortical network 
activity. Transmembrane currents in neurons also produce local electric fields that 
induce “ephaptic coupling” (nonsynaptic electrical coupling) between adjacent 
axons, which influences the synchronization and timing of action potential firing in 
neurons [31].
Another biofield phenomenon is the coherent, ultraweak photon emissions 
(UPE), detected from cell cultures and from the body surface. The fluctuations 
in UPE correlate with cerebral blood flow, cerebral energy metabolism, and EEG 
activity. Photonic stimulation at one end of a nerve increases UPE at the other end. 
Nonconventional means of UPE-mediated biosignaling include wave propaga-
tion within longitudinally oriented neuronal microtubules and passage through 
membrane-spanning regions of proteins that may serve as “light pipes” [32].
Numerous nonneural electrical fields have been detected and analyzed, 
including those arising from patterns of resting membrane potentials that guide 
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development and regeneration, and from slowly varying transepithelial direct 
current fields that initiate cellular responses against tissue damage. In addition to 
the high-speed electrical signals conducted along nerve axons, a second communi-
cation network, based in ubiquitous epithelial cells, conducts information through 
varying direct currents, which spread across considerable distances and play key 
roles in recognizing damage and guiding cell migration necessary for wound heal-
ing especially in skin, heart, and cornea as well as in regulating the migration of 
neuronal path-finding.
Electrical fields—created by either mechanical stress (piezoelectricity) or stream-
ing potentials—in bone, tendons, and fascia regulate the functioning of osteocytes 
and fibroblasts to adjust the density of supporting tissues in response to loads [33].
Unspecialized “loose” connective tissue, referred as fascia, forms a continuous 
head-to-toe network surrounding and permeating all tissues and organs. As an 
extracellular matrix, structured mainly by collagen fibers, fascia provides a sup-
portive and regulatory framework for all organs of the body as it coordinates cel-
lular perception and interpretation of mechanical forces. This extracellular system 
reaches into the interior of cells via transmembrane bridging molecules known as 
integrins, which allow information from the fascia to modify cell metabolism and 
genetic activity. Since collagen structures both conduct and modify photon pulses 
emitted from biological sources, signaling along collagen fibers serves as a surveil-
lance system of endogenous biofield emission to complement the immune and 
nervous systems in monitoring tissue health.
Further speculation based on the water-protein relationship along collagen 
fibers invokes quantum coherence, a state that can occur when all water molecules 
in a particular domain or region are spinning synchronously, emitting spin or tor-
sion waves. Such spin coherence and quantum coherence enable the collagen matrix 
to be ultrasensitive to electromagnetic fields in a manner that can be frequency 
selective due to a quantum phenomenon known as the Larmor Precession [34].
Global coherence is the multilevel integration of diverse biological activities 
across time and scale accounts for the most salient properties such as long-range 
order and coordination, rapid and efficient energy transfer, and extreme sensitivity 
to specific signals.
The receptor system for endogenous and exogenous biofields is a body-wide 
network that exhibits three types of potential receptor sites: molecular, charge flux, 
and endogenous field.
An important series of studies on cultured cells identified two examples of the 
first type of receptor sites—deoxyribonucleic acid (DNA) and the cell membrane—
at which exogenous electromagnetic signals exert specific biological effects.
Charge flux sites, the second type of receptor as exemplified by the perturbation 
of transmembrane calcium fluxes, have been proposed as a generic mechanism by 
which weak electromagnetic fields affect biological systems.
Low-frequency electromagnetic fields also interact with DNA by accelerating 
the movement of electrons within the helical arrays of base pairs. While ion chan-
nels and ion pumps have major roles in establishing the resting potential of an 
individual cell, the gap junctions, which are the specialized electrical connections 
between adjacent cells, allow voltage and current-mediated signals to be propagated 
across groups of cells. In this manner, spatiotemporal patterns of resting potentials 
arise to provide bioelectrical guidance during tissue development, regeneration, 
and cancer suppression [35].
Deletion of the electromagnetic response elements (EMRE) eliminates the 
ability of the applied electromagnetic field to regulate the target genes, while other 
genes can be converted from electromagnetic nonresponders to responders by 
inserting the EMRE at upstream regions.
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Sufficient evidence has accrued to consider biofield physiology as a scientific 
discipline, based on nonlocal, integrated, information-conveying phenomena 
as well as on emerging molecular details of localized biophysical interactions. 
Endogenously generated pulses of ultraweak photons, electromagnetic fields, and 
patterns of distributed membrane voltage are varied forms of physiological activity 
designated as biofields, each with established properties and proposed biological 
functions.
While bioelectromagnetics define the mechanisms of local interactions, 
biofield physiology is more about understanding the integrated, longer-range 
functions within the whole organism: the former more reductive and the latter 
more integrative [36].
While the nervous, endocrine, immune, and cardiovascular systems are in 
continuous intercommunication via electrical and molecular signals, endogenous 
biofields act as carriers of information between these systems. An example is heart-
brain interaction, where several types of cardiac initiated signals appear to exert 
sequential effects on brain activity. Electromagnetic signals from the heart reach 
the brain in a relatively instantaneous manner, followed first by a range of neural 
signals arriving in millisecond timeframes and subsequently by pressure waves and 
hormonal signals arriving with delays of seconds [37].
Evidence of DNA response elements that respond to specific electromagnetic 
frequencies, analogous to DNA regions responsive to specific hormones, is an 
important finding.
Different types of signals mediating rapid/short-acting vs. slower/longer-lasting 
responses, neurally released adrenaline and hormonally released corticosteroids, 
respectively, coordinate the stress response. Physiological requirements for ultra-
rapid responses may be met by biofields. Raman and infrared spectroscopic tech-
niques are now enabling rapid and sensitive chemical characterization of samples 
based strictly on the vibrational signatures of the molecules present in a sampling 
volume. When applied to biological systems, the techniques provide highly complex 
spectra that document changes taking place in the entire genome, proteome, and 
metabolome; real-time in vivo applications are possible.
Biomarkers, defined as physiological variables that have significant clinical 
relevance to the population being studied, may include measures of immune, 
endocrine, psychophysiological, autonomic nervous system (including skin con-
ductance), and other neural functions (including electroencephalography, positron 
emission tomography). Biomarkers may indicate which physiological systems are 
affected by biofield therapy but do not necessarily shed light on the pathways by 
which these changes occur nor on the transduction events by which practitioner 
activity is converted to patient responses that initiate the cascade of physiological 
changes [38–42].
An increasing number of physicians and other health care providers have begun 
integrating biofield therapies into patient care, and a growing number of hospital-
based programs offer these modalities to patients. The line between what is “alter-
native,” “complementary,” or “integrative” is often blurred when it comes to biofield 
therapies, their practice, and their use by patients.
In the book, one chapter will be about biofield interpretation.
Healing is a multidimensional process that is strengthened by reducing stress 
and accessing psychospiritual resources, congruent with their values, beliefs, and 
philosophical perspectives on life and well-being.
There is a need to re-evaluate all the traditional practices on a scientific base to 
complement and integrate into the conventional evidence-based medicine. In the 
last chapter, there is a trial to review and present the current situation and future 
trends in this integration.
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